BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36232726)

  • 1. Mucopolysaccharidosis-Plus Syndrome: Report on a Polish Patient with a Novel
    Lipiński P; Szczałuba K; Buda P; Zakharova EY; Baydakova G; Ługowska A; Różdzyńska-Świątkowska A; Cyske Z; Węgrzyn G; Pollak A; Płoski R; Tylki-Szymańska A
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation in VPS33A affects metabolism of glycosaminoglycans: a new type of mucopolysaccharidosis with severe systemic symptoms.
    Kondo H; Maksimova N; Otomo T; Kato H; Imai A; Asano Y; Kobayashi K; Nojima S; Nakaya A; Hamada Y; Irahara K; Gurinova E; Sukhomyasova A; Nogovicina A; Savvina M; Yoshimori T; Ozono K; Sakai N
    Hum Mol Genet; 2017 Jan; 26(1):173-183. PubMed ID: 28013294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homozygous missense VPS16 variant is associated with a novel disease, resembling mucopolysaccharidosis-plus syndrome in two siblings.
    Yıldız Y; Koşukcu C; Aygün D; Akçaboy M; Öztek Çelebi FZ; Taşcı Yıldız Y; Şahin G; Aytekin C; Yüksel D; Lay İ; Özgül RK; Dursun A
    Clin Genet; 2021 Sep; 100(3):308-317. PubMed ID: 34013567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Juvenile mucopolysaccharidosis plus disease caused by a missense mutation in VPS33A.
    Pavlova EV; Lev D; Michelson M; Yosovich K; Michaeli HG; Bright NA; Manna PT; Dickson VK; Tylee KL; Church HJ; Luzio JP; Cox TM
    Hum Mutat; 2022 Dec; 43(12):2265-2278. PubMed ID: 36153662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
    Zhang H; Wood T; Young SP; Millington DS
    Mol Genet Metab; 2015 Feb; 114(2):123-8. PubMed ID: 25458519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucopolysaccharidosis-Plus Syndrome.
    Vasilev F; Sukhomyasova A; Otomo T
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
    Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS.
    Byers S; Rozaklis T; Brumfield LK; Ranieri E; Hopwood JJ
    Mol Genet Metab; 1998 Dec; 65(4):282-90. PubMed ID: 9889015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucopolysaccharidosis-Plus Syndrome, a Rapidly Progressive Disease: Favorable Impact of a Very Prolonged Steroid Treatment on the Clinical Course in a Child.
    Faraguna MC; Musto F; Crescitelli V; Iascone M; Spaccini L; Tonduti D; Fedeli T; Kullmann G; Canonico F; Cattoni A; Dell'Acqua F; Rizzari C; Gasperini S
    Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lysosomal disease caused by mutant VPS33A.
    Pavlova EV; Shatunov A; Wartosch L; Moskvina AI; Nikolaeva LE; Bright NA; Tylee KL; Church HJ; Ballabio A; Luzio JP; Cox TM
    Hum Mol Genet; 2019 Aug; 28(15):2514-2530. PubMed ID: 31070736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic Disorders, Renal Impairment and Growth in Mucopolysaccharidosis-Plus Syndrome.
    Sofronova V; Iwata R; Moriya T; Loskutova K; Gurinova E; Chernova M; Timofeeva A; Shvedova A; Vasilev F; Novgorodova S; Terawaki S; Moriwaki T; Sukhomyasova A; Maksimova N; Otomo T
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bi-allelic VPS16 variants limit HOPS/CORVET levels and cause a mucopolysaccharidosis-like disease.
    Sofou K; Meier K; Sanderson LE; Kaminski D; Montoliu-Gaya L; Samuelsson E; Blomqvist M; Agholme L; Gärtner J; Mühlhausen C; Darin N; Barakat TS; Schlotawa L; van Ham T; Asin Cayuela J; Sterky FH
    EMBO Mol Med; 2021 May; 13(5):e13376. PubMed ID: 33938619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newborn screening and diagnosis of mucopolysaccharidoses.
    Tomatsu S; Fujii T; Fukushi M; Oguma T; Shimada T; Maeda M; Kida K; Shibata Y; Futatsumori H; Montaño AM; Mason RW; Yamaguchi S; Suzuki Y; Orii T
    Mol Genet Metab; 2013; 110(1-2):42-53. PubMed ID: 23860310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of monosaccharides and disaccharides in mucopolysaccharidoses patients by electrospray ionisation mass spectrometry.
    Ramsay SL; Meikle PJ; Hopwood JJ
    Mol Genet Metab; 2003 Mar; 78(3):193-204. PubMed ID: 12649064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of an Affordable Method for MPS Diagnosis from Urine Screening to Enzymatic Confirmation: Results of a Pilot Study in Morocco.
    Fdil N; Sabir ES; Ezoubeiri A; Elqadiry R; Daoudi A; Lalaoui A; Fouad A; Rada N; Slitine N; Bennaoui F; Bourrahouat A; Saab IA; Boualy B; Karim A; Andrade F; González-Lamuňo D; Aldámiz-Echevarria L; Bouskraoui M
    Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of mucopolysaccharidoses in a clinically selected population by urinary glycosaminoglycan analysis: a study of 2,000 urine samples.
    Piraud M; Boyer S; Mathieu M; Maire I
    Clin Chim Acta; 1993 Nov; 221(1-2):171-81. PubMed ID: 8149634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updated Confirmatory Diagnosis for Mucopolysaccharidoses in Taiwanese Infants and the Application of Gene Variants.
    Chuang CK; Tu YR; Lee CL; Lo YT; Chang YH; Liu MY; Liu HY; Chen HJ; Kao SM; Wang LY; Ho HJ; Lin HY; Lin SP
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of reliability for urine mucopolysaccharidosis screening by dimethylmethylene blue and Berry spot tests.
    Mabe P; Valiente A; Soto V; Cornejo V; Raimann E
    Clin Chim Acta; 2004 Jul; 345(1-2):135-40. PubMed ID: 15193988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycan-based biomarkers for mucopolysaccharidoses.
    Lawrence R; Brown JR; Lorey F; Dickson PI; Crawford BE; Esko JD
    Mol Genet Metab; 2014 Feb; 111(2):73-83. PubMed ID: 23958290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and molecular analysis of mucopolysaccharidoses in Turkey.
    Emre S; Terzioğlu M; Coşkun T; Tokath A; Ozalp I; Müller V; Hopwood J
    Turk J Pediatr; 2002; 44(1):13-7. PubMed ID: 11858372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.